Impact of isometheptene enantiomers in human blood vessels in vitro and rat middle meningeal artery

Lire cet article en français

Takeaway

  • Isometheptene enantiomers do not constrict the human coronary artery in vitro and therefore have a relatively safe peripheral vascular profile in migraine.

Why this matters

  • Racemic isometheptene is an antimigraine drug that has previously been separated into its enantiomers, (R)- and (S)-isometheptene as a result of cardiovascular side-effect concerns but do not appear to modulate neurogenic calcitonin gene-related peptide (CGRP) release so the mechanism of anti-migraine activity remains unknown.

Vous souhaitez en lire plus ?

Vous souhaitez en lire plus ?

Connectez-vous à votre compte ou inscrivez-vous à Neurodiem pour consulter la suite.

Vous avez déjà un compte ? S'identifier

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.